Literature DB >> 16388192

Consistency of the benefits of stroke units over years of operation: an 8-year effectiveness analysis.

Blanca Fuentes1, Exuperio Díez-Tejedor, M Angeles Ortega-Casarrubios, Patricia Martínez, Manuel Lara, Ana Frank.   

Abstract

BACKGROUND: The efficacy of stroke units (SU) has been amply demonstrated in randomised trials. However, no long-term studies analysed their effectiveness in daily practice over several years of operation.
METHODS: Observational study from the stroke data bank of our neurology ward that includes consecutive stroke patients hospitalised since the SU was established in 1995 until the year 2002 (8 years). Clinical effectiveness was analysed in terms of mortality on day 7, in-hospital mortality, functional state at discharge, length of stay, in-hospital complications and long-term hospitalisation rates on a yearly basis using for comparisons chi2 or Student t tests between the first and last 4 years of SU operation. Case-mix adjustments for baseline imbalances and stepwise multivariate logistic regression were also performed for comparative purposes.
RESULTS: 3,986 consecutive in-patients were included. No significant differences in the proportion of independent patients at discharge (73.9 vs. 74.5%; n.s.), length of stay (11.2 vs. 11.3 days; n.s.), in-hospital complications (25.0 vs. 25.9%; n.s.) or long-stay hospitalisation (6.3 vs. 6.4%; n.s.) were found comparing the first and last 4 years of SU operation. No significant differences in in-hospital mortality were found after adjustment by case-mix and length of stay.
CONCLUSIONS: SU effectiveness, in terms of length of stay, death or dependence and long-term hospitalisation, is sustained over the period of operation. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16388192     DOI: 10.1159/000090529

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  8 in total

1.  Emergency management of ischemic stroke in children.

Authors:  Maja Steinlin; Mark T Mackay
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

2.  Effect of anticoagulation on cardioembolic stroke severity, outcomes and response to intravenous thrombolysis.

Authors:  Ignacio Illán-Gala; Patricia Martínez-Sánchez; Blanca Fuentes; Yudy Llamas-Osorio; Javier Díaz de Terán; Melissa Báez; Gerardo Ruiz-Ares; Borja Enrique Sanz-Cuesta; Manuel Lara-Lara; Exuperio Díez-Tejedor
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

3.  Severity and outcomes according to stroke etiology in patients under 50 years of age with ischemic stroke.

Authors:  Daniel Prefasi; Patricia Martínez-Sánchez; Blanca Fuentes; Exuperio Díez-Tejedor
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

4.  Acute ischemic stroke patients with diabetes should not be excluded from intravenous thrombolysis.

Authors:  Blanca Fuentes; Andrés Cruz-Herranz; Patricia Martínez-Sánchez; Ana Rodríguez-Sanz; Gerardo Ruiz Ares; Daniel Prefasi; Borja E Sanz-Cuesta; Manuel Lara-Lara; Exuperio Díez-Tejedor
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

5.  Intravenous thrombolysis in stroke patients under 55 years of age: is there a different effect according to etiology and severity?

Authors:  Daniel Prefasi; Blanca Fuentes; Patricia Martínez-Sánchez; Ana Rodríguez-Sanz; Gerardo Ruiz-Ares; Borja Sanz-Cuesta; Manuel Lara Lara; Exuperio Díez-Tejedor
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

6.  Recent advances in management of cerebrovascular diseases.

Authors:  Khurshid Khan; Ashfaq Shuaib
Journal:  F1000 Med Rep       Date:  2009-06-29

7.  Changes in survival and characteristics among older stroke unit patients-1994 versus 2012.

Authors:  Angela Susan Labberton; Ole Morten Rønning; Bente Thommessen; Mathias Barra
Journal:  Brain Behav       Date:  2018-11-25       Impact factor: 2.708

8.  Beneficial effects of stroke-unit care in stroke patients with atrial fibrillation.

Authors:  Hye-Yeon Choi; Joo Hyun Seo; Jae Hoon Yang; Young Dae Kim; Yo Han Jung; Han Jin Cho; Hyo Suk Nam; Ji Hoe Heo
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.